Gloria Lee, MD, PhD

/

Chief Medical Officer

Dr. Lee leads HUYABIO clinical research and development of the oncology portfolio. With over 28 years in big pharma and biotech, she specializes in taking small molecules through cell-based therapy products from early clinical stage to marketing approval. Prior to HUYABIO, Gloria served at Delcath Systems and Kite Pharma, established the registration-enabling clinical development for abiraterone at Cougar Biotechnology and participated in Taxotere’s NDA and Rhône-Poulenc Rorer Gencell’s label expansion programs. Her clinical development work included ibandronate at Hoffmann-La Roche, tezacitabine at Chiron and various early-phase biologics and immunotherapy projects. Dr. Lee received a PhD from Columbia University and an MD from the University of Miami, completed her internal medicine residency at Georgetown University Hospital and Hematology-Oncology fellowship at Fox Chase Cancer Center.